Fischli, S
University of North Carolina at Chapel Hill · Seoul National University · Novo Nordisk (Denmark) · Medical University of Graz · Atlanta Diabetes Associates · KU Leuven
2 papers on CoChatORCID 0000-0003-1659-343X
Most cited papers
- Verified
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Pieber, T. R., Bode, B., Mertens, A., Cho, Y. M., Christiansen, E., Hertz, C. L., Wallenstein, S. O. R., Buse, J. B., Akın, S., Aladağ, N., et al. (2019) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 287
- Verified
Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma
Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012) · The Journal of Clinical Endocrinology & Metabolism
Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free